| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5636300 | Burns | 2017 | 4 Pages |
Abstract
NICE (The National Institute for Health and Care Excellence) states that Recell® shows potential to improve healing in acute burns and we believe that its co-delivery with fibrin via Vivostat® (Vivostat A/S, Lillerød, Denmark) allows for precise delivery of the fibrin suspended cells while minimising loss in the “run off” encountered when Recell® is just simply sprayed on, assisting the anchoring of keratinocytes to the wound surface and thus aiding in the treatment of challenging areas.
Related Topics
Health Sciences
Medicine and Dentistry
Critical Care and Intensive Care Medicine
Authors
Philippa Johnstone, Johnny Sheng-Sun Kwei, George Filobbos, Darren Lewis, Steven Jeffery,